Genex Pharmaceutical Inc

Chart & Performance

D1W1MN

P/E

0.01

P/S

0.00

EPS

0.02

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

8.36%

Revenues

+32.77%

Net income

343k

-44.66%

CFO

530k

-55.12%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.

URL

IPO date

May 23, 2006

Employees

Domiciled in

Incorporated in

Valuation

No data to show